Answers are grounded in this paper and cite their sources.
The use of lazaroids specifics of thrombolytic drug therapy monoclonal antibodies in the treatment of shock pharmacologic approaches to the eldely patient, the critically-ill patient, plus updates on treating paediatric patients pharmacology of muscle relaxation, such as during ventilation pharmacologic treatment of stroke cholinergic agents in treating conditions such as myasthenia gravis treatment of Parkinson's Disease and other muscle spasms immunosuppressive therapy in transplantation and other circumstances special considerations for bicarbonate therapy and resuscitation of hyponatremia use of surfacant in infant distress syndrome and adult respiratory distress syndrome.
No takes yet. Share an insight, caveat, or question.
A 1988 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: